Renke Maas

14PUBLICATIONS
46CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesMolecular medicineToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 16, 2026
A distributed analysis approach for pharmacovigilance data from electronic medical records in German university hospitals: the POLAR_MI ETL Pipeline.

|Jun 12, 2026
Artificial intelligence-powered chatbots for oral anticancer drug patient information: an assessment of quality.

|Aug 28, 2025
Role of Transport Proteins for the Renal Handling of L-Arginine and Related Derivatives.

Lorenz A Scherpinski, Jörg König, Renke Maas

|Jun 24, 2025
Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins.

Lorenz A Scherpinski, Martin F Fromm, Renke Maas

|Nov 08, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics".

Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe

|Jul 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC.

Michael I Sponfeldner, Wahram Andrikyan, Renke Maas

Pageof 3

Frequent Collaborators

8 joint publications

Martin F Fromm

6 joint publications

Wahram Andrikyan

4 joint publications

Pauline Dürr

2 joint publications

Niklas Kehl